
1. plos pathog. 2008 jul 4;4(7):e1000096. doi: 10.1371/journal.ppat.1000096.

vaccinia virus e3 protein prevents antiviral action isg15.

guerra s(1), cáceres a, knobeloch kp, horak i, esteban m.

author information: 
(1)department molecular cellular biology, centro nacional de biotecnología
csic, campus universidad autónoma, madrid, spain. sguerra@cnb.csic.es

the ubiquitin-like modifier isg15 one predominant proteins induced
by type interferons (ifn). study, murine embryo fibroblast (mefs) and
mice lacking gene used demonstrate novel role isg15 host
defense molecule vaccinia virus (vacv) infection. mefs, growth 
replication competent western reserve (wr) vacv strain affected the
absence isg15, addition, virus lacking e3 protein (vvdeltae3l) 
unable grow isg15+/+ cells replicated isg15-deficient cells. inhibiting 
isg15 sirna promoting expression isg15-/- cells lentivirus 
vector showed vacv replication controlled isg15. immunoprecipitation 
analysis revealed e3 binds isg15 c-terminal domain. vacv
antiviral action isg15 interaction e3 events independent of
pkr (double-stranded rna-dependent protein kinase). mice lacking isg15,
infection vvdeltae3l caused significant disease mortality, effect not
observed vvdeltae3l-infected isg15+/+ mice. pathogenesis isg15-deficient
mice infected vvdeltae3l e3l deletion mutant virus lacking the
c-terminal domain triggered enhanced inflammatory response lungs
compared isg15+/+-infected mice. findings showed anti-vacv function
of isg15, virus e3 protein suppressing action isg15 antiviral
factor.

doi: 10.1371/journal.ppat.1000096 
pmcid: pmc2434199
pmid: 18604270  [indexed medline]

